Diabetes
Conference Coverage
Therapy app cut A1c, drug intensification in T2D
Livin' on the MDedge
A purple warrior rises in the battle against diabetes
Plus: Rare honey builds strong but bacteria-prone bone implants, and mycoprotein builds strong gut microbiomes.
Feature
How to get started with prescribing and advising on CGM
Continuous glucose monitoring is gaining ground with both patients and providers because of an array of driving forces.
From the Journals
Diabetes drug tied to lower dementia risk
Risk for dementia is doubled in adults with T2DM, say the authors of a new paper.
From the Journals
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
From the Journals
Type 1 diabetes no longer a disease of the thin: Lifestyle advice needed
The prevalence of overweight/obesity was similar for people with type 1 diabetes and those without diabetes in a nationwide survey.
Feature
Dapagliflozin gets expanded heart failure indication in Europe
The European Commission has expanded the indication of the SGLT2 inhibitor to include HF with mildly reduced and preserved ejection fraction.
From the Journals
Longer life after bariatric surgery, but suicide risk in young
Death from diabetes was 72% lower in the bariatric surgery patients versus nonsurgery peers.
Commentary
Keto for life? Reasons to think twice
Is the Keto diet best for weight loss? Maybe in the short term, but it’s more complicated than that. Dr. Caroline Apovian explains why.
From the Journals
Persistent gaps in drug use by patients with type 2 diabetes
Continuous use of glucose-, BP-, and cholesterol-lowering medications by adults with mainly type 2 diabetes declined in 2005-2019. This may...
From the Journals
In adults with prediabetes, vitamin D cuts diabetes risk
Vitamin D reduced the risk for diabetes in people with prediabetes by a statistically significant 15%, in a meta-analysis.